Abacavir antiretroviral therapy and indices of subclinical vascular disease in persons with HIV.
Claudia A MartinezRishi RikhiMollie S PesterMeela ParkerAlex GonzalezMichaela E LarsonJennifer V ChavezArmando MendezJeffrey K RainesMichael A KolberIvonne H SchulmanMaria L AlcaideBarry E HurwitzPublished in: PloS one (2022)
Findings indicate that ABC treatment of 30-50 year-old PWH on stable ART is not likely to contribute in a robust way to higher CVD risk.